Utilizing complementary unbiased functional genomics approaches, we have identified CSNK1E as a gene essential for Wnt/β-catenin signaling and survival in a subset of breast cancers that exhibit aberrant β-catenin activity. This evidence concerns the gene CSNK1E and breast carcinoma.